除了呼吸困扰综合征之外的表面活性剂的使用,有什么证据?
Riddhi K Desai1, Hilal Yildiz Atar2, Satyan Lakshminrusimha3
1Division of Neonatology, University of Texas Southwestern Medical Center, Dallas, TX, USA. riddhi.desai@utsouthwestern.edu.
概括
表面活性剂治疗已被批准用于患有呼吸困扰综合征 (RDS) 的早产婴儿,在非标签的使用中显示出有前途的潜力,用于满期婴儿和急性呼吸衰竭. 目前正在进行进一步的研究,以评估表面活性剂缺乏和药物输送应用.
科学领域:
- 新生儿医学 新生儿医学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 表面活性剂替代疗法是FDA批准的早产婴儿呼吸困扰综合征 (RDS) 由于表面活性剂缺乏.
- 确定的好处包括减少RDS的早产婴儿的死亡率和空气泄漏综合征.
- 标签之外的表面活性剂的使用正在探索各种呼吸系统衰竭,超出了经典的RDS.
研究的目的:
- 审查新生儿呼吸衰竭中非标签表面活性剂治疗的现有证据.
- 探索表面活性剂在有期婴儿中使用,这些婴儿患有诸如美吸收综合征 (MAS),肺炎/败血症和先天性隔膜等疾病.
- 在72小时以后的早产婴儿中检查表面活性剂的使用,以检查急性呼吸衰竭和表面活性剂洗.
主要方法:
- 对非标签表面活性剂治疗的当前证据的文献综述.
- 分析研究调查表面活性剂在具有特定肺部疾病的预产婴儿中的使用.
- 对早产婴儿延长使用和表面活性剂洗技术的研究评估.
主要成果:
- 证据支持表面活性剂在特定非标签的新生儿呼吸系统疾病中的有效性.
- 该审查强调了正在进行的关于表面活性剂在药物输送和缺陷评估中的作用的研究.
- 标签外的应用显示在管理复杂的新生儿呼吸系统问题方面具有潜在的益处.
结论:
- 表面活性剂替代疗法已经扩大了应用范围,超出了其批准的适用性.
- 需要进一步调查,以确定非标签地使用表面活性剂的最终准则.
- 表面活性剂具有新的治疗策略的潜力,包括药物输送和诊断表面活性剂缺乏.
相关概念视频
01:05Breathing
59.2K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.2K
01:29Acute Respiratory Failure-V
138
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
138
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
285
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
285
01:17Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
01:19Respiratory Assessment: Purpose and Indications
1.1K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.1K
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442